Immunoglobulin Y: an IgG-like antibody with an IgE-like structure?
Immunoglobulin Y: an IgG-like antibody with an IgE-like structure?
批准号:
BB/D011418/1
负责人:
Brian Sutton
金额:
$37.31万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The human immune system provides protection against foreign invading organisms including parasites, bacteria and viruses, through a variety of different cells, such as the white blood cells, and proteins, such as the antibodies. In man, as in other mammals, there are specialized types of antibodies: a type known as IgG deal principally with viruses and bacteria, while another, called IgE, is produced in defence against parasites. However, in regions of the world where parasitic infections no longer present a challenge, these IgE antibodies are instead produced in response to substances that we call allergens. People with a tendency to produce high levels of IgE are especially susceptible to allergies, such as hayfever, asthma and food allergies. We have been studying IgE antibodies in order to understand how they cause allergy, and have discovered that there is a particular part of the antibody molecule, present in IgE but not in IgG, which gives it special properties. In particular, it causes the IgE molecules to stick extremely tightly to cells and activate them when parasites invade the body. Although this is very effective against parasites, it unfortunately has the same effects, which include a sudden inflammation reaction, when allergens such as grass pollen, bee venom or particular foods, for example peanuts, enter the body. The effects of these sudden allergic reactions are well-known, and can even be fatal. One aim of our work in this field is to develop improved drugs to treat these conditions. There is however much that we have yet to learn about the human immune system, such as the 'polarization' into the IgG and IgE type responses, and why only certain molecules that we know as allergens provoke the IgE response. One way of approaching this is from an evolutionary standpoint. Birds do not have IgG or IgE, but instead have a single type of antibody called IgY. In fact, an IgY-like antibody was present in the last common ancestor of birds and mammals, 300 million years ago, and was the evolutionary predecessor of IgG and IgE. IgY combines in a single molecule the properties of both IgG and IgE, yet birds do respond differently to viruses and parasites in their immune response, despite having only one type of antibody. We propose to study IgY from chickens, since they have the best-studied non-mammalian immune system. The publication last year of the complete DNA sequence of the chicken genome has greatly enhanced these studies. In particular, we propose to isolate the molecules to which IgY binds on the surfaces of cells, and we are the first, to our knowledge, to have identified such a 'receptor' for IgY. We shall study how IgY binds to cells, and aim to discover how it combines the roles of both IgG and IgE, thus helping us to understand, and perhaps then prevent, the unwanted IgE allergic response in man. One of the outcomes of this research is therefore an improved understanding of the human immune system and its evolution, with future benefits for human medicine. However, improved understanding of the chicken immune system is not without its own benefits. Poultry meat is an important source of human disease, and the control of bacterial disease in chickens is largely based on an indiscriminate use of antibiotics; this over-use of antibiotics has severely reduced their usefulness in controlling human bacterial infections, as the emergence of strains of antibiotic-resistant 'super-bugs' has shown. A better understanding of the chicken immune system may lead to better ways of controlling bacterial infection in these commercially important animals. Chickens and other avian species can also harbour viruses that can in turn threaten man, such as the recent outbreak of avian 'flu, and improved knowledge of immunity in birds may help us to understand how this transmission process occurs.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Allergy genes flew the coop, according to evolutionary analysis.
根据进化分析,过敏基因已经消失。
DOI:
10.1038/nm0808-797a
发表时间:
2008
期刊:
Nature medicine
影响因子:
82.9
作者:
[Ballantyne C]
通讯作者:
Ballantyne C
DOI:
10.1021/bi8019993
发表时间:
2009-01
期刊:
Biochemistry
影响因子:
2.9
作者:
[A. I. Taylor;S. Fabiane;B. Sutton;R. Calvert]
通讯作者:
A. I. Taylor;S. Fabiane;B. Sutton;R. Calvert
Mutations in an avian IgY-Fc fragment reveal the locations of monocyte Fc receptor binding sites.
禽类 IgY-Fc 片段的突变揭示了单核细胞 Fc 受体结合位点的位置。
DOI:
10.1016/j.dci.2009.08.012
发表时间:
2010
期刊:
Developmental and comparative immunology
影响因子:
2.9
作者:
[Taylor AI]
通讯作者:
Taylor AI
RUI: Commutativity in Numerical Computation
-
批准号:2012216
-
项目类别:Standard Grant
-
资助金额:$6.46万
-
财政年份:2020
-
负责人:Brian Sutton
-
依托单位:
Structural studies to advance understanding of IgM and its complement and receptor interactions
-
批准号:BB/K006142/1
-
项目类别:Research Grant
-
资助金额:$48.42万
-
财政年份:2012
-
负责人:Brian Sutton
-
依托单位:
Allergenicity and allergen dominance: structural requirements for IgE-dependent recognition by B cells & effector cells
-
批准号:G1100090-E01/1
-
项目类别:Research Grant
-
资助金额:$186.78万
-
财政年份:2011
-
负责人:Brian Sutton
-
依托单位:
Stable and efficient computation of the CS decomposition
-
批准号:0914559
-
项目类别:Standard Grant
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:Brian Sutton
-
依托单位:
Exploring, Understanding and Intervening in IgE-dependent Mechanisms in Allergic Disease and Asthma
-
批准号:G0501494/1
-
项目类别:Research Grant
-
资助金额:$292.37万
-
财政年份:2006
-
负责人:Brian Sutton
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向AChR抗体IgG N-糖基化的重症肌无力精准治疗策略研究
-
批准号:2026JJ50565
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐立群
-
依托单位:
BLyS/APRIL-T-bet+B细胞轴促进IgG4相关性疾病进展的机制研究
-
批准号:JCZRQNB202600591
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
温肾健脾化痰方通过调控IgG介导的TGF-β/SMAD通路改善衰老脂肪炎症和纤维化的作用机制
-
批准号:JCZRLH202600788
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
FGFR3-IgG经GPCR/cAMP通路诱导GFAP-A
时周围神经损伤的效应和炎症机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:龙友明
-
依托单位:
结直肠癌肿瘤来源IgG驯化B细胞导致免
疫治疗耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘依娜
-
依托单位:
特发性膜性肾病血清标志物anti-PLA2R-IgG4检测方法的建立及临床应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:徐燕
-
依托单位:
IDOT检测NMOSD相关抗体AQP4-IgG效能的前瞻性、多中心、开放标签、盲法评价的临床研究
-
批准号:2024Y9178
-
项目类别:省市级项目
-
资助金额:150.0万元
-
批准年份:2024
-
负责人:李锐
-
依托单位:
功能性畜血源免疫球蛋白IgG的绿色制造
与稳态化关键技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
Ⅰ型血小板反应蛋白7A域(THSD7A)抗体IgG 检测试剂盒
开发及产业化
-
批准号:2024JJ8219
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吴荣桂
-
依托单位:
M2型巨噬细胞在IgG4相关性疾病中作用机制的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位: